Research Article
Issues around the Prescription of Half Tablets in Northern Switzerland: The Irrational Case of Quetiapine
Table 3
Ten most frequently split medications given by active substances (SPC: Summary of Product Characteristics).
|
Active substance (original brand name) | Proportion of split tablets [%] |
Splitting is explicitly mentioned in the SPC (yes/no) | Total (cumulative) | Quarter 1/4 | Half 1/2 | Three-quarter 3/4 |
| Pipamperone (Dipiperon) | 15.8 | 6.2 | 9.3 | 0.3 | y | Levodopa/decarboxylase inhibitor (Madopar) | 10.2 (26.0) | — | 10.1 | 0.1 | y | Quetiapine (Seroquel, Sequase) | 6.5 (32.5) | 0.3 | 6.2 | — | n | Lorazepam (Temesta) | 5.1 (37.6) | 0.4 | 4.7 | — | y | Mirtazapine (Remeron, generics) | 4.3 (41.9) | — | 4.3 | — | y | Torasemide (Torem, generics) | 3.9 (45.8) | 2.2 | 1.2 | 0.5 | y | Zolpidem (Stilnox, generics) | 3.2 (49.0) | — | 3.2 | — | y | Metoprolol (Beloc ZOK, generics) | 2.7 (51.7) | — | 2.7 | — | y | Citalopram (Seropram, generics) | 2.7 (54.4) | — | 2.7 | — | y | Risperidone (Risperdal) | 2.6 (57.0) | — | 2.6 | — | n |
|
|